Australian Journal of General Practice · Apr 2026

Demystifying menopausal hormone therapy prescribing

By Magraith K, Jang C

BACKGROUND: Menopause and perimenopause are associated with vasomotor symptoms and other symptoms that can affect quality of life. Menopausal hormone therapy (MHT) improves menopausal symptoms and reduces the risk of osteoporosis and fracture. OBJECTIVE: This article provides an updated overview of the basic principles of prescribing MHT, including the risks and benefits and practical information for tailoring treatment to the individual. DISCUSSION: Women presenting at menopause should have a comprehensive assessment including updated health screening and promotion of a healthy lifestyle. MHT can be offered to women with symptoms in the absence of contraindications, following a discussion about risks and benefits. MHT comprises systemic oestrogen, and for those with an intact uterus, a progestogen.

doi.org/10.31128/ajgp-12-25-7923Open accessPubMed 41942075Interventions

AgingResearch.News